Skip to main content
logo
TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
59.83
+1.85 (3.18%)
At close: Nov 6, 2026, 4:00 PM EST
59.75
-0.08 (-0.13%)
After-hours: Nov 6, 2026, 7:45 PM EST

TG Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Nov '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Market Capitalization
8,4867,7864,9064,3585,2705,2485,7264,3203,3552,5472,2022,4161,1803,4502,0701,5848015651,2442,4884,350
Market Cap Growth (YoY)
57.03%48.37%-14.33%0.89%57.08%106.08%160.03%78.80%184.34%-26.19%6.39%52.51%47.36%510.45%66.43%-36.33%-81.59%-88.83%-80.12%-62.88%38.46%
Enterprise Value
8,6888,0255,0184,4815,2735,2265,6704,2333,2512,4492,0962,2971,1443,4191,9921,4916864111,0082,1593,943
Last Close Price
59.8354.9433.2229.8136.1335.9939.4330.1023.3917.7915.2117.088.3624.8415.0411.835.924.259.5119.0033.28

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Nov '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
21.6117.6410.629.7511.7886.80146.27184.75-233.5926.61---45.55--------
Forward PE
31.2031.3224.9720.2926.1130.9837.1045.2156.40198.33134.45134.45134.45--------
PS Ratio
10.619.747.017.079.9111.5614.8213.1312.677.357.6110.346.22143.45241.51569.04159.3681.19157.20371.96987.39
PB Ratio
14.0512.898.416.738.6818.9824.1319.4317.4614.3413.7515.057.1685.2975.4627.047.974.387.3010.4913.97
P/TBV Ratio
14.0512.898.416.738.6818.9824.1319.4317.4614.3413.8215.057.2087.0177.7227.418.034.417.3310.5314.00
P/FCF Ratio
488.13447.87--174.42--88.59---37.55---28.04--------
P/OCF Ratio
474.72435.57--175.93--88.76---37.55---28.05--------
PEG Ratio
1.392.070.140.140.170.270.330.37-------------

EV Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Nov '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
EV/Sales Ratio
10.8710.047.177.279.9111.5114.6712.8712.287.067.249.836.03142.15232.36535.43136.4359.07127.45322.82894.81
EV/EBITDA Ratio
63.6758.8233.5536.3251.2860.8594.70100.79-7968.0724.01---61.19--------
EV/EBIT Ratio
63.7358.8733.5736.3451.3160.8894.78100.95-6437.5724.04---60.40--------
EV/FCF Ratio
499.76461.63--179.34--88.23---36.10---27.19--------

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Nov '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Debt / Equity Ratio
1.251.251.290.390.420.921.071.141.320.640.700.690.672.703.951.420.820.620.470.340.09
Debt / EBITDA Ratio
5.458.495.331.252.131.806.972.084.883.01--0.24--------
Debt / FCF Ratio
43.4043.40--10.18--4.30---1.67---2.62--------
Net Debt / Equity Ratio
0.340.340.410.170.200.01-0.09-0.25-0.45-0.59-0.61-0.66-0.72-0.89-1.14-1.34-0.93-0.89-0.90-0.99-1.05
Net Debt / EBITDA Ratio
1.481.481.600.911.200.03-0.36-1.35213.81-1.02-2.01-5.106.370.210.190.410.400.410.480.680.97
Net Debt / FCF Ratio
11.6311.63-16.85-4.50-1.75-0.040.351.403.10-1.54-4.823.392.830.220.190.450.390.420.540.801.26
Asset Turnover
0.680.680.640.750.660.820.750.730.581.121.010.890.690.100.030.010.020.020.020.010.01
Inventory Turnover
0.931.191.051.120.740.480.460.630.450.420.370.860.440.27-------
Quick Ratio
3.553.554.852.912.532.812.914.853.652.772.765.004.662.242.353.044.834.524.284.844.09
Current Ratio
4.274.275.814.103.833.864.026.254.593.583.625.925.532.872.933.165.024.684.435.064.24
Return on Equity (ROE)
100.28%100.28%112.60%102.75%111.96%26.63%19.70%12.21%-8.05%87.78%43.93%11.57%-19.53%-207.28%-170.41%-151.36%-115.86%-112.66%-106.06%-92.03%-142.26%
Return on Assets (ROA)
7.28%7.28%8.55%9.39%7.98%9.72%7.26%5.78%-0.07%20.46%10.59%4.93%-4.31%-44.63%-40.71%-47.61%-46.55%-48.41%-47.32%-42.87%-61.92%
Return on Invested Capital (ROIC)
16.74%19.43%23.26%20.49%23.13%44.56%39.97%34.84%-2.17%139.07%77.60%38.11%-41.46%-----2055.08%-1962.97%--
Return on Capital Employed (ROCE)
9.90%9.90%11.10%13.60%11.80%16.20%12.00%8.60%-0.10%34.80%17.70%7.50%-6.90%-113.80%-121.40%-137.40%-128.80%-136.30%-129.80%-109.70%-105.10%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Nov '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Earnings Yield
4.63%5.67%9.41%10.26%8.49%1.15%0.68%0.54%-0.43%3.76%1.87%0.52%-2.20%-5.09%-8.14%-12.52%-29.80%-51.05%-26.25%-13.99%-7.88%
FCF Yield
0.20%0.22%-0.29%-0.57%-1.33%-1.13%-1.07%-0.94%-0.84%2.66%0.92%-1.30%-3.57%-4.65%-8.09%-11.12%-29.88%-48.14%-22.78%-11.90%-6.00%
Buyback Yield / Dilution
5.56%3.25%1.66%0.55%-0.18%-1.97%-11.33%-11.99%-3.11%-12.66%-4.20%-4.36%-15.18%-4.99%-4.40%-3.43%-2.25%-2.05%-1.90%-6.74%-11.06%
SEC Filings: 10-K · 10-Q